相关实验视频
Updated: Jun 14, 2025
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
15.9K
药物标 孟德尔随机化应用于与代谢功能障碍相关的脂肪性肝病:机遇和挑战
Shan Luo1, Ming-Hua Zheng2,3, Vincent Wai-Sun Wong4,5
1School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
eGastroenterology
|February 13, 2025
概括
药物标门德尔随机化 (MR) 提供了一种强大的方法来发现和验证新治疗代谢功能障碍相关的脂肪性肝病 (MASLD) 的新疗法. 这种基因方法有助于识别新的药物点,并评估MASLD现有的安全性.
科学领域:
- 遗传学和基因组学 在
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是全球慢性肝病的主要原因,影响超过33%的成年人.
- 尽管更新了诊断标准,但对MASLD的治疗进展仍然受到限制.
- 针对MASLD的药物开发面临重大挑战,需要创新方法.
研究的目的:
- 审查药物标孟德尔随机化 (MR) 在MASLD研究中的实用性.
- 探索MR在发现,重新定位和评估MASLD药物点安全性的作用.
- 在MASLD的背景下,为设计和评估MR研究提供见解.
主要方法:
- 利用人类遗传学和基因组学数据用于药物向的门德尔随机化 (MR).
- 总结设计和评估药物向MR研究的关键方面.
- 在 MASLD.中讨论假设,仪器选择和现实世界的例子.
主要成果:
- 药物向MR显示了在MASLD中识别新型治疗点的潜力.
- MR可以促进对现有药物的重新定位,用于MASLD治疗.
- MR有助于评估药物标的安全性,并为辅助疗法提供信息,包括儿科MASLD.
结论:
- 药物向MR是一种有价值的遗传方法,可以促进MASLD药物发现和开发.
- 在MASLD中,MR为目标识别,验证和安全评估提供了一个强大的框架.
- 进一步应用MR可以加速为不断增长的MASLD人群开发有效的治疗方法.
相关概念视频
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
34
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
34
01:24Overview of Lipid Metabolism
1.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.2K